Abstract-In the present study, we investigated whether prostaglandin E1 (PGE1)
We have reported that the administration of prostaglandin E, (PGE,) diminishes the number of immune complexes in the glomeruli in serum sickness nephritic rats (1, 2). A couple of routes for the disposal of macro molecules from the glomerulus have been proposed (3) . One of the routes is through mesangial channels: macromolecules could be drained from the glomerulus via these pathways (4) (5) (6) . Another is phagocytosis by the mesangial cells and/or resident mesangial cells (7, 8) . In previous studies, we demon strated that PGE1 failed to accelerate the disposal of colloidal carbon via mesangial channels. We prepared a BSA according to the method of Ford (9) . Briefly, crystallized BSA (Miles) was dis solved in sterilized saline (Otsuka Seiyaku) to obtain a 3% solution. The solution was adjusted to pH 10 with 0.2 N NaOH, and the optical density was measured at the wave length of 525 nm in a spectrophotometer.
The solution was then heated to 70°C in a water bath with shaking for 20 min and then to 79'C for further 15 min. The solution was cooled to room temperature and the optical density again determined. The pH was ad justed to 7.5 with 0.2 N HCI. The preparation was centrifuged at 1500 g at 4°C for 30 min just before intravenous injection.
The molecular weight of intact BSA was about 6.5X104 daltons according to SDS polyacrylamide electrophoresis.
A-BSA con sisted of molecules with molecular weights of 5.0x105, 1 x106 and 2.8 X 106 daltons when applied to a gel filtration-column using Cellulofine GCL-2000-st (Seikagaku Ko gyo)
3. Detection of glomerular a-BSA: We used an immunoperoxidase staining kit (Strabigen, BioGenex Laboratories) to determine the location of a-BSA in the glomerulus.
The kidney was fixed with 10% buffered formalin and embedded in paraffin. A deparaffinized section was treated with 0.01% protease (Type VIII, Sigma) solution for 20 min at room temperature;
and after rinsing with tap water and phosphate-buffered saline (PBS), tissue peroxidase activity was blocked with 3.0% H202 solution. The section was incubated with anti-BSA serum (Chappel) in a moist chamber at 6-8°C overnight. After rinsing with PBS, each anti-rabbit IgG conjugated with biotin and streptoavidin conjugated with horseradish peroxidase was allowed to react with the section in the moist chamber at room temperature for 20 min. After washing in PBS for 10 min, the section was incubated with 0.05% 3,3 diaminobenzidine•4HCl (DAB, Bethesda
Reseach Laboratories Life Technologies) in 0.1 M Tris-HCI buffer, pH 7.2, containing one drop of 3.0% H202 for 10 min at room temperature.
For immunofluorescence, another kidney was "snap" frozen with n-hexane in dry ice acetone, cut at a thickness of 4 ,em in a cryostat, and stained with FITC-conjugated anti-BSA rabbit serum (Cappel) in a moist chamber at 37'C for 3 hr. 4 . Changes in glomerular a-BSA: Mice were injected i.v. with 90 mg/100 g body weight of a-BSA, 3 times, at 4 hr intervals. The kidneys were isolated 4, 8, 12, 14, 16, 24, 36 and 48 hr after the first injection of a-BSA.
The right kidney was stained immunohisto chemically as described above. The total area of a-BSA per glomerular cross section (GCS) was measured for 30 glomeruli per section using an image analyzer (Luzex 500) and presented as ,em2/GCS. The left kidney was stained with FITC-conjugated anti-BSA serum as described above. The degree of fluorescence in the 50 glomeruli was graded from -to +++.
5. Effects of drugs on disposal of glomer ular a-BSA (Fig. 1 ): The mice that had re ceived i.v. 90 mg/100 g body weight of a BSA 3 times were treated with a drug at 12 hr after the first administration of a-BSA, and the kidney was isolated at 16 hr. We deter mined the total area of a-BSA in the glomer ulus by an immunohistochemical technique in combination with the use of an image ana lyzer.
PGE1, PGE2 and PGF2a were purchased from Funakosi Yakuhin. They were dissolved in absolute ethanol and diluted with PBS, as reported previously (2 
Results
1. Localization of a-BSA in the glomerulus (Photos 1 and 2): As shown in photo 1, a BSA was mainly observed in the mesangium and along the capillary wall in a granular pattern by using the immunofluorescence technique 12 h,r after the first injection of a-BSA. Additionally, a few glomeruli show a lump of a-BSA located in only the me sangium. However, no a-BSA was observed in the space of the interstitium and the con voluted tubules. A-BSA was observed in the section stained by the immunohistochemical technique in almost the same location in the glomerulus as that found by immunofluores cence (photo 2).
2. Changes in glomerular a-BSA (Fig. 2 ): In the immunohistochemical observations, a-BSA deposited in the glomerulus was 160.4 um2/GCS, the area of a-BSA at 4 hr after the first injection of a-BSA. The total area of a-BSA at 8 hr was similar to that at 4 hr. Thereafter, the amount of the glomerular a-BSA increased quickly, and attained a peak at 14 hr (397.1 um2/GCS), and then decreased to 32.4 um2/GCS by 36 hr and to 19.8 ,M2/GCS by 48 hr.
In the immunofluorescence findings, the time course of glomerular a-BSA was similar to that in the immunohistochemical findings. The amount of a-BSA reached a peak at 12 hr after the first a-BSA injection and then de clined promptly. Glomerular a-BSA could not be detected by 36 hr later. A-BSA was located in the mesangium and along the capillary wall at 12 and 14 hr, and then the a-BSA in the mesangium rapidly disappeared with time. Finally, we could only observe a small amount of a-BSA along the capillary wall.
3. Effects of drugs on disposal of glmer ular a-BSA (Figs. 3 and 4) : As shown in Fig.  3 , administration of 300 and 400 ug/mouse PGE, resulted in more prompt disposal of glomerular a-BSA than in the control (228.9 and 217.5 /,M2/GCS for PGE, groups and 348.4 ,um2/GCS for the control group). The 300 /cg/mouse PGE, group had 34.3% less a-BSA than the control group. The 400 fig/ mouse PGE, group had 37.6% less a-BSA than the control group. Furthermore, 200 ,ug/ mouse of PGE, tended to have less glomer ular a-BSA (15.0%) than control group. How ever, the administration of 150 fig/mouse PGE1 had no effect on the disposal of glomer ular a-BSA. Figure 4 shows that as compared to the amount of glomerular a-BSA in the control group, 389.6 itm2/GCS, the 400 fig/mouse PGE2 group showed a significantly lower amount, 143.4 fcm2/GCS (63.2% of the con trol). The 200 fig/mouse PGE2 group tended to have less glomerular a-BSA (14.4%) than the control group.
Administrations of PGF2a did not have any effect on the glomerular a-BSA. 
Discussion
Many tracers have been utilized as probes in experiments concerning glomerular uptake and glomerular disposal of macromolecules (3). A-BSA was used as a probe in the cur rent experiment since we thought that a-BSA deposited in the glomerulus may be de graded through mesangial phagocytosis.
In deed, a-BSA was found to be located in the mesangium in our immunofluorescence and immunohistochemical studies, which is con sistent with the observations of Ford (9) . In the present experiment, the level of glomeru lar a-BSA peaked at 14 hr and promptly disappeared by 48 hr, whereas colloidal carbon was in the mesangium over 3 weeks after its injection according to a previous report (10) . Colloidal carbon stays in the glomerular mesangium because it can not be degraded by mesangial phagocytosis, but glomerular a-BSA promptly disappears from the glomeruli because it can be degraded through this process.
Furthermore, Lee et 
